D.A. DAVIDSON & CO. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$293,619
-47.5%
53,875
-35.3%
0.00%
-50.0%
Q2 2023$558,775
+17.8%
83,275
+55.0%
0.01%
+20.0%
Q1 2023$474,392
+61.7%
53,725
+39.9%
0.01%
+66.7%
Q4 2022$293,376
-0.9%
38,400
-7.6%
0.00%
-25.0%
Q3 2022$296,000
-8.9%
41,550
+3.4%
0.00%0.0%
Q2 2022$325,000
-5.5%
40,165
+62.0%
0.00%0.0%
Q1 2022$344,000
-31.7%
24,795
+38.2%
0.00%
-20.0%
Q4 2021$504,000
-11.7%
17,945
+6.9%
0.01%
-28.6%
Q3 2021$571,000
-12.2%
16,785
+5.5%
0.01%
-12.5%
Q2 2021$650,000
+5.0%
15,910
+3.4%
0.01%0.0%
Q1 2021$619,000
-1.6%
15,385
+44.7%
0.01%
-20.0%
Q4 2020$629,000
+20.5%
10,635
-0.9%
0.01%
+11.1%
Q3 2020$522,000
-2.1%
10,735
-2.5%
0.01%
-10.0%
Q2 2020$533,000
+17.1%
11,015
-32.8%
0.01%
+11.1%
Q1 2020$455,000
+14.6%
16,390
+23.5%
0.01%
+50.0%
Q4 2019$397,00013,2700.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders